| | 135062-02-1 Basic information More.. |
| Product Name: | Repaglinide | | Synonyms: | AG-EE-623 ZW;(S)-2-Ethoxy-4-[2-[[3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid;Repaglinide,(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid, Novonorm, Prandin;Repaglinide (200 mg)G0D2760.999mg/mg(ai);Repaglinide (200 mg);(S)-2-Ethoxy-4-[2-[[[(1S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butyl]aMino]-2-oxoethyl]benzoic Acid;Repaglinide(AG-EE 623ZW);Rebaglinide | | CAS: | 135062-02-1 | | MF: | C27H36N2O4 | | MW: | 452.59 | | EINECS: | 629-921-1 | | Mol File: | 135062-02-1.mol |  |
Use
Repaglinide, a type of medicines for treating diabetes, is insulinotropic agent which belongs to the non-sulfonylurea. It was developed by Boehringer Ingelheim from Germany, and won approval by FDA from the United States in December 1997. In 1998, it was successively listed in the United States and European countries, with commodity name as NovoNorm. Mainly used in the clinical treatment of typeⅡdiabetes (non-insulin-dependent) patients whose hyperglycemia can’t be effectively controlled via diet, weight loss and exercise.
- Repaglinide
-
- US $0.00 / kg
- 2024-04-13
- CAS:135062-02-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000kg
- Repaglinide
-
- US $8.00-1.00 / KG
- 2024-03-29
- CAS:135062-02-1
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: g-kg-tons, free sample is available
- Repaglinide
-
- US $35.00-25.00 / kg
- 2024-03-15
- CAS:135062-02-1
- Min. Order: 1kg
- Purity: 99.8%
- Supply Ability: 200tons/year
|
|
135062-02-1
Recommend Suppliers |
|